Evidence map›Paper›PMID 31529306›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Rapid culture-based identification of Shiga toxin-producing Escherichia coli and Shigella spp./Enteroinvasive E. coli using the eazyplex® EHEC complete assay.

Anika Penzel, Katrin Schützler, Jana Dröge, Alexander Mellmann, Ralf Ehricht, Ines Engelmann, Sascha D Braun, Benjamin T Schleenvoigt, Bettina Löffler, Jürgen Rödel

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Development and Validation of the MAST ISOPLEXInternational journal of molecular sciences · 2024
    Article
  3. Virulence Factors of Enteric PathogenicInternational journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Anika PenzelInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Katrin SchützlerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Jana DrögeInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Alexander MellmannInstitute of Hygiene and National Consulting Laboratory for Hemolytic Uremic Syndrome (HUS), University Hospital Münster, Münster, Germany.
Ralf EhrichtLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.
Ines EngelmannBlink AG, Jena, Germany.
Sascha D BraunLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.
Benjamin T SchleenvoigtInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Jürgen RödelInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany. juergen.roedel@med.uni-jena.de.
Jena University Hospital · DELeibniz Institute of Photonic Technology · DEUniversity Hospital Münster · DE

Funding

Bundesministerium für Bildung und Forschung 13N13890
6 · The paper itself

Abstract

Shiga toxin-producing Escherichia coli (STEC) and Shigella spp./enteroinvasive E. coli (EIEC) are common diarrheagenic bacteria that cause sporadic diseases and outbreaks. Clinical manifestations vary from mild symptoms to severe complications. For microbiological diagnosis, culture confirmation of a positive stool screening PCR test is challenging because of time-consuming methods for isolation of strains, wide variety of STEC pathotypes, and increased emergence of non-classical strains with unusual serotypes. Therefore, molecular assays for the rapid identification of suspect colonies growing on selective media are very useful. In this study, the performance of the newly introduced eazyplex® EHEC assay based on loop-mediated isothermal amplification (LAMP) was evaluated using 18 representative STEC and Shigella strains and 31 isolates or positive-enrichment broths that were collected from clinical stool samples following screening by BD MAX™ EBP PCR. Results were compared to real-time PCR as a reference standard. Overall, sensitivities and specificities of the eazyplex® EHEC were as follows: 94.7% and 100% for Shiga toxin 1 (stx1), 100% and 100% for stx2, 93.3% and 97.1% for intimin (eae), 100% and 100% for enterohemolysin A (ehlyA), and 100% and 100% for invasion-associated plasmid antigen H (ipaH) as Shigella spp./EIEC target, respectively. Sample preparation for LAMP took only some minutes, and the time to result of the assay ranged from 8.5 to 13 min. This study shows that eazyplex® EHEC is a very fast and easy to perform molecular assay that provides reliable results as a culture confirmation assay for the diagnosis of STEC and Shigella spp./EIEC infections.

Indexed as

AdultChild, PreschoolColony Count, MicrobialCulture MediaDNA, BacterialDysentery, BacillaryEnterohemorrhagic Escherichia coliEscherichia coli InfectionsFecesFemaleFood MicrobiologyHumansNucleic Acid Amplification TechniquesProspective StudiesSensitivity and SpecificityShiga-Toxigenic Escherichia coliCulture MediaDNA, BacterialE. coliLAMPShiga toxinShigellaStool culture

Identifiers

PMID31529306
OpenAlexW2973551273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.